- Infection-acquired immunity cut the risk of hospitalization and death from a Covid reinfection by 88% for at least 10 months, the study found.
- People who had hybrid immunity, or immunity from both infection and vaccination, were excluded.
- The study was the largest meta-analysis to date to look at immunity following infection.
The immunity generated from an infection was found to be “at least as high, if not higher” than that provided by two doses of an mRNA vaccine.
Covid Infection acquired immunity
Immunity acquired from a Covid infection provides strong, lasting protection against the most severe outcomes of the illness, according to research published Thursday in The Lancet — protection, experts say, that’s on par with what’s provided through two doses of an mRNA vaccine.
Infection-acquired immunity cut the risk of hospitalization and death from a Covid reinfection by 88% for at least 10 months, the study found.
Protection against severe diseases
“This is really good news, in the sense that protection against severe disease and death after infection is really quite sustained at 10 months,” said the senior study author, Dr. Christopher Murray, the director of the Institute for Health Metrics and Evaluation at the University of Washington.
The findings may be a small silver lining to the explosive omicron outbreak of last winter. With so many people infected, many most likely still benefit from that protection against severe disease, Murray said.
Still, experts stress that vaccination is the preferable route to immunity, given the risks of Covid, particularly in unvaccinated people.
“The problem of saying ‘I’m gonna get infected to get immunity’ is you might be one of those people that end up in the hospital or die,” Murray said.
“Why would you take the risk when you can get immunity through vaccination quite safely?”
Study performed on
The study was the largest meta-analysis to date to look at immunity following infection. It included 65 studies from 19 countries and compared the risk of developing Covid again in people who had recovered from infections to people who hadn’t been infected through September.
People who had hybrid immunity, or immunity from both infection and vaccination, were excluded.
Omicron subvariants that emerged in the late fall and early winter of last year, including BQ.1 and the now-dominant XBB.1.5, weren’t included.
Protection from reinfection
While protection from severe disease remained high, people could be reinfected — particularly with an omicron subvariant — consistent with evidence that protection against having symptoms wanes faster than protection against hospitalization and death.
Having Covid before the omicron variant emerged didn’t do much to stop reinfection with the mutated version: Protection from reinfection in that case was 74% after one month but fell to 36% by month 10.
Dr. Bob Wachter, the chairman of the department of medicine at the University of California, San Francisco, said he did not expect the protection acquired from infection to be as robust as the meta-analysis found.
“The protection against severe infection, both the extent and the length of it at almost a year, is really surprisingly high,” said Wachter, who was not involved with the research.
Infection-acquired immunity outperforms vaccines
The immunity generated from an infection was found to be “at least as high, if not higher” than that provided by two doses of an mRNA vaccine, the authors wrote.
While Murray and Wachter agreed that vaccination remains the safest route, having a past Covid infection should at least be considered in policy making decisions going forward, such as vaccination requirements, they said.
“What Europe did with this evidence made a lot of sense, which is where evidence of past infection was seen as essentially equal to vaccination in terms of requirements to go into events or for employment,” Murray said.
Did you subscribe to our Newsletter?
It’s Free! Click here to Subscribe.
Source: NBC
